Alzheimer's Research & Therapy | Volume 1 Issue 1

Advanced Search

Submit a manuscript Register

Explore journal

Advertisement

Advertisement

Articles

cover

		Volume 1 Issue 1
		Comment
		Commentary Alzheimer's disease therapeutic research: the path forward Paul S Aisen Alzheimer's Research & Therapy 2009, 1:2 (9 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Despite recent negative trial results, a clear path forward is emerging in Alzheimer’s disease therapeutic research using newly available tools to allow the study of new treatments at earlier stages in the disease process.
		Editorial Welcome to Alzheimer's Research & Therapy Ann Donnelly, Doug Galasko, Todd Golde, Frances Mulvany, Gordon Wilcock Alzheimer's Research & Therapy 2009, 1:1 (9 July 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Douglas Galasko, Todd Golde and Gordon Wilcock, Editors-in-chief, introduce Alzheimer’s Research & Therapy, the major forum for translational research into Alzheimer’s disease.
		Review
		Review Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND) Blossom CM Stephan, Fiona E Matthews, Kay-Tee Khaw, Carole Dufouil, Carol Brayne Alzheimer's Research & Therapy 2009, 1:4 (9 July 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Stephan et al. review the concept of ‘vascular cognitive impairment, no dementia’ (VCIND) and its application for screening individuals at increased risk of dementia secondary to vascular disease and its risk factors.
		Review Angiotensins and Alzheimer's disease: a bench to bedside overview Patrick G Kehoe Alzheimer's Research & Therapy 2009, 1:3 (9 July 2009) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Kehoe proposes angiotensins and associated enzymatic pathways as important mediators of recognized but undefined links between blood pressure and Alzheimer’s disease.

Advertisement

Advertisement